Wang, Xiaowei <br/><br/>
Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.  [electronic resource] 

 -  Circulation research  Mar 2014 
 - 1083-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4571 
<br/><br/><label>Standard No.: </label>10.1161/CIRCRESAHA.114.302514  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Platelets--drug effects<br/>CHO Cells<br/>Carotid Arteries--diagnostic imaging<br/>Cricetinae<br/>Cricetulus<br/>Drug Evaluation, Preclinical<br/>Fibrinolytic Agents--adverse effects<br/>Integrin alpha2--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Plasminogen--metabolism<br/>Platelet Activation<br/>Recombinant Fusion Proteins--genetics<br/>Single-Chain Antibodies--genetics<br/>Thromboembolism--drug therapy<br/>Thrombolytic Therapy<br/>Ultrasonography<br/>Urokinase-Type Plasminogen Activator--genetics